Pharmacists must clear their shelves of diclofenac tablets as the product is being recalled over health fears.
Related Article: What will hub and spoke changes mean for independents?
According to an alert by the Medicines and Healthcare Products Regulatory Agency (MHRA) on Wednesday 14 January, diclofenac is associated with a “small but increased” risk of serious cardiac side effects in some patients, if used at high does and for long-term treatment.
Diclofenac creams have been unaffected by the alert.
Related Article: NICE approves once-a-day pill linzagolix for endometriosis
The Commission on Human Medicines deemed side effects too serious and pharmacies have been notified to not sell diclofenac over the counter.
Deputy director of vigilance and risk management at the MHRA, Dr Sarah Branch, said: “People who have been prescribed diclofenac from their doctor should continue to take their medicine as instructed as their medical history and any tests will already have been assessed. If you have any questions about your treatment you should discuss this with your doctor at the next visit.”
Related Article: Thinktank recommends 'fluid' supervision throughout ARRS career
In August 2013, the MHRA consulted on the availability of oral diclofenac after an European review found the slight increase in cardiac side effects.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.